Market surveillance
Bonnes Pratiques pour la gestion des ruptures d’approvisionnement d’un médicament vétérinaire (19/02/2024)
Historique des ruptures critiques clôturées (28/02/2025)
Current critical shortages
Rupture BTVPUR SUSPENSION INJECTABLE POUR OVINS ET BOVINS - (26/02/2025)
Rupture EQUIP ARTERVAC EMULSION INJECTABLE POUR CHEVAUX ET PONEYS - Actualisation (26/02/2025)
Rupture ALBEX GOLD 200 MG/ML SUSPENSION BUVABLE POUR BOVINS - (10/01/2025)
Rupture VALBAZEN - (20/12/2024)
Rupture PALMIVAX - (14/11/2024)
Rupture PRECALCY D3 - (23/04/2024)
Each identified quality defect is assessed according to a procedure shared by the industry and ANMV. The risk assessment carried out successively by the two parties determines the criticality of the damage that the quality defect may cause to the health of the animals to be treated, or even indirectly to human health.
Procedure for managing quality defects and batch recalls for veterinary drugs (PDF).